Physician profile
Germina Suffrant
NPI 1831319003
$8,467.62
in general payments reported to CMS, 2019-2025
10 companies · $31.78 in 2025
The $31.78 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2021: $120 · 2022: $11.95 · 2023: $6,387 · 2024: $1,788 · 2025: $31.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Travel and Lodging: $3,356 · Food and Beverage: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Travel and Lodging | $3,355.67 |
| Food and Beverage | $351.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,045.71 | 2023-2024 | Davinci Xi, Da Vinci Surgical System, Da Vinci Sp |
| Pfizer INC. | $111.20 | 2019-2023 | |
| Glaxosmithkline, LLC. | $107.47 | 2021 | |
| Optumhealth Care Solutions, LLC | $94.76 | 2024-2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Duchesnay USA Incorporated | $24.46 | 2019 | |
| Abbvie INC. | $20.23 | 2019 | |
| Minerva Surgical, INC | $17.65 | 2025 | |
| Avion Pharmaceuticals | $16.03 | 2019 | |
| Exeltis, USA INC. | $15.81 | 2023 | Slynd |
| Sanofi-Aventis U.S. LLC | $14.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Germina Suffrant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.